Based in Gothenburg, Sweden, Emeriti Bio is a privately owned company founded in 2015. It is led by an experienced and dedicated management team with strong knowledge of the pharmaceutical industry
Björn Wallmark - Chairman of the Board, PhD in biochemistry, worked with AstraZeneca for 27 years, and Schering AG for 5 years.
Jan Fryklund - CEO, PhD in Pharmacology, 35 years within AstraZeneca, Department head for many years.
David Gustafsson - Member of the board, MD and PhD in pharmacology, worked with AstraZeneca for 28 years.
Tomas Fex - Member of the Board, PhD in organic chemistry, 30 years of experience from pharmaceutical companies in Sweden, 10 years at AstraZeneca.
Bengt Ohlsson - PhD in organic chemistry, worked with AstraZeneca for 25 years.
Lars Gustafsson - Member of the Board, previous managing director and chairman of the Nordic branch of Euler Hermes, a credit insurance company.
Registered drugs and brands that we have had a major influence on: Losec®/Prilosec®, Nexium®, Plendil®, Exanta®, Brilinta®